Aspirin will become an acceptable prophylactic agent on Jan. 1, 2014 under the Surgical Care Improvement Project measures for patients undergoing elective total knee or total hip replacement, according to an AAOS Now report.
Currently, orthopedic surgeons that use aspirin and mechanical compression as venous thromboembolism prophylaxis for knee and hip surgery must document it in the patient's chart with a note specifying aspirin was selected because of concerns about bleeding. However, after the first of the year this notation is no longer necessary, according to the report.
More Articles on Orthopedic Surgery:
Illinois Bone & Joint Enters Partnership for CMS Bundled Payment Initiative
WilsonOrtho Opens Urgent Care Center
18 Professional Athletes Receiving Orthopedic Surgery